Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 261425, 8 pages
Review Article

Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review

1Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
2University of Sydney, Sydney, NSW 2006, Australia
3Centre for Kidney Disease Research, Translational Research Institute, University of Queensland, Brisbane, QLD 4102, Australia

Received 27 April 2015; Accepted 11 June 2015

Academic Editor: Juraj Majtan

Copyright © 2015 Anna Francis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Infection is a major cause of morbidity and mortality at all stages of chronic kidney disease (CKD). Multiresistant organisms are becoming increasingly common, particularly in the CKD population. Unfortunately, the rapid evolution of antibiotic resistance has not been mirrored by innovation in new antibiotic agents. Novel treatments are therefore urgently needed. Honey has garnered much interest due to its broad-spectrum antibacterial properties based on extensive experimental data. Unlike conventional antibiotics, honey has an added advantage as it appears to avoid inducing antimicrobial resistance in bacteria. This review discusses the potential mechanisms of action and role of honey in infection management in the general population, epidemiology and special challenges of infections in CKD populations, and the clinical trial evidence pertaining to the safety and efficacy of honey for the prevention and treatment of infections in CKD population.